Theralase Technologies Inc. - Asset Resilience Ratio

Latest as of September 2006: 5.90%

Theralase Technologies Inc. (TLT) has an Asset Resilience Ratio of 5.90% as of September 2006. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read TLT current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CA$219.63K

≈ $158.87K USD Cash + Short-term Investments

Total Assets

CA$3.72 Million

≈ $2.69 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2004–2005)

This chart shows how Theralase Technologies Inc.'s Asset Resilience Ratio has changed over time. See Theralase Technologies Inc. (TLT) shareholders funds for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Theralase Technologies Inc.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Theralase Technologies Inc. market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CA$0.00	0%
Short-term Investments	CA$219.63K	5.9%
Total Liquid Assets	CA$219.63K	5.90%

Asset Resilience Insights

Limited Liquidity: Theralase Technologies Inc. maintains only 5.90% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Theralase Technologies Inc. Industry Peers by Asset Resilience Ratio

Compare Theralase Technologies Inc.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
INKON Life Technology Co Ltd SHE:300143	Medical Devices	3.37%
CareRay Digital Medical Technology Co Ltd SHG:688607	Medical Devices	16.21%
Senseonics Holdings, Inc. Common Stock NYSE MKT:SENS	Medical Devices	54.67%
Universus Photo Imagings Limited NSE:UNIVPHOTO	Medical Devices	30.97%
HansBiomed Corporation KQ:042520	Medical Devices	9.13%
Aligned Genetics Inc KQ:238120	Medical Devices	2.22%
Heramed Ltd AU:HMD	Medical Devices	0.83%
Acarix A/S ST:ACARIX	Medical Devices	37.81%

Annual Asset Resilience Ratio for Theralase Technologies Inc. (2004–2005)

The table below shows the annual Asset Resilience Ratio data for Theralase Technologies Inc..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2005-12-31	8.86%	CA$314.50K ≈ $227.51K	CA$3.55 Million ≈ $2.57 Million	-23.98pp
2004-12-31	32.84%	CA$399.01K ≈ $288.64K	CA$1.22 Million ≈ $878.97K	--

pp = percentage points

About Theralase Technologies Inc.

V:TLT Canada Medical Devices

Market Cap

$58.45 Million

CA$80.80 Million CAD

Market Cap Rank

#21286 Global

#746 in Canada

Share Price

CA$0.31

Change (1 day)

-4.69%

52-Week Range

CA$0.15 - CA$0.39

All Time High

CA$0.58